|
|
||||||||
1From the Departments of Oncology and 3Biostatistics, St. Jude Childrens Research Hospital and the 4Departments of Ophthalmology and Anatomy and 2Neurobiology, University of Tennessee Health Sciences Center, Memphis, Tennessee.
PURPOSE. Mice lacking the Arf tumor-suppressor gene develop eye disease reminiscent of persistent hyperplastic primary vitreous (PHPV). The current work explores mechanisms by which Arf promotes eye development, and its absence causes a PHPV-like disease.
METHODS. Chimeric mice were made by fusing wild-type and Arf/ morulae. In these experiments, wild-type cells are identified by transgenic expression of GFP from a constitutive promoter. PCR-based genotyping and quantitative analyses after immunofluorescence staining of tissue and cultured cells documented the relative contribution of wild-type and Arf/ cells to different tissues in the eye and different types of cells in the vitreous.
RESULTS. The contributions of the Arf/ lineage to the tail DNA, cornea, retina, and retina pigment epithelium (RPE) correlated with each other in wild-type
Arf/ chimeric mice. Newborn chimeras had primary vitreous hyperplasia, evident as a retrolental mass. The mass was usually present when the proportion of Arf/ cells was relatively high and absent when the Arf/ proportion was low. The Pdgfrß- and Sma-expressing cells within the mass arose predominantly from the Arf/ population. Ectopic Arf expression induced smooth muscle proteins in cultured pericyte-like cells, and Arf and Sma expression overlapped in hyaloid vessels.
CONCLUSIONS. In the mouse model, loss of Arf in only a subset of cells causes a PHPV-like disease. The data indicate that both cell autonomous and noncell autonomous effects of Arf may contribute to its role in vitreous development.
This article has been cited by other articles:
![]() |
N. E. Freeman-Anderson, Y. Zheng, A. C. McCalla-Martin, L. M. Treanor, Y. D. Zhao, P. M. Garfin, T.-C. He, M. N. Mary, J. D. Thornton, C. Anderson, et al. Expression of the Arf tumor suppressor gene is controlled by Tgf{beta}2 during development Development, June 15, 2009; 136(12): 2081 - 2089. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, S. Fuhrmann, and M. L. Vetter A Nonautonomous Role for Retinal Frizzled-5 in Regulating Hyaloid Vitreous Vasculature Development Invest. Ophthalmol. Vis. Sci., December 1, 2008; 49(12): 5561 - 5567. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |